BACKGROUND: The authors evaluated the effectiveness and cost effectiveness of 2 interventions designed to promote colorectal cancer (CRC) screening in safety-net settings. METHODS: A 3-arm, quasi-experimental evaluation was conducted among 8 clinics in Louisiana. Screening efforts included: 1) enhanced usual care, 2) literacy-informed education of patients, and 3) education plus nurse support. Overall, 961 average-risk patients ages 50 to 85 years were eligible for routine CRC screening and were recruited. Outcomes included CRC screening completion and incremental cost effectiveness using literacy-informed education of patients and education plus nurse support versus enhanced usual care. RESULTS: The baseline screening rate was <3%. After the interventions, the screening rate was 38.6% with enhanced usual care, 57.1% with education, and 60.6% with education that included additional nurse support. After adjusting for age, race, sex, and literacy, patients who received education alone were not more likely to complete screening than those who received enhanced usual care; and those who received additional nurse support were 1.60-fold more likely to complete screening than those who received enhanced usual care (95% confidence interval, 1.06-2.42; P = .024). The incremental cost per additional individual screened was $1337 for education plus nurse support over enhanced usual care. CONCLUSIONS: Fecal occult blood test rates were increased beyond enhanced usual care by providing brief education and nurse support but not by providing education alone. More cost-effective alternatives to nurse support need to be investigated.
BACKGROUND: The authors evaluated the effectiveness and cost effectiveness of 2 interventions designed to promote colorectal cancer (CRC) screening in safety-net settings. METHODS: A 3-arm, quasi-experimental evaluation was conducted among 8 clinics in Louisiana. Screening efforts included: 1) enhanced usual care, 2) literacy-informed education of patients, and 3) education plus nurse support. Overall, 961 average-risk patients ages 50 to 85 years were eligible for routine CRC screening and were recruited. Outcomes included CRC screening completion and incremental cost effectiveness using literacy-informed education of patients and education plus nurse support versus enhanced usual care. RESULTS: The baseline screening rate was <3%. After the interventions, the screening rate was 38.6% with enhanced usual care, 57.1% with education, and 60.6% with education that included additional nurse support. After adjusting for age, race, sex, and literacy, patients who received education alone were not more likely to complete screening than those who received enhanced usual care; and those who received additional nurse support were 1.60-fold more likely to complete screening than those who received enhanced usual care (95% confidence interval, 1.06-2.42; P = .024). The incremental cost per additional individual screened was $1337 for education plus nurse support over enhanced usual care. CONCLUSIONS: Fecal occult blood test rates were increased beyond enhanced usual care by providing brief education and nurse support but not by providing education alone. More cost-effective alternatives to nurse support need to be investigated.
Keywords:
colorectal cancer screening; community health clinics; fecal occult blood test; federally qualified health centers; literacy; low-income patients
Authors: Ronald E Myers; Randa Sifri; Terry Hyslop; Michael Rosenthal; Sally W Vernon; James Cocroft; Thomas Wolf; Jocelyn Andrel; Richard Wender Journal: Cancer Date: 2007-11-01 Impact factor: 6.860
Authors: Allen J Dietrich; Jonathan N Tobin; Andrea Cassells; Christina M Robinson; Meredith Reh; Karen A Romero; Ann Barry Flood; Michael L Beach Journal: Ann Fam Med Date: 2007 Jul-Aug Impact factor: 5.166
Authors: Stephen H Taplin; David Haggstrom; Tracy Jacobs; Ada Determan; Jennifer Granger; Wanda Montalvo; William M Snyder; Susan Lockhart; Ahmed Calvo Journal: Med Care Date: 2008-09 Impact factor: 2.983
Authors: Michael S Wolf; Alfred Rademaker; Charles L Bennett; M Rosario Ferreira; Nancy C Dolan; Terry C Davis; Franklin Medio; Dachao Liu; June Lee; Marian Fitzgibbon Journal: Prev Chronic Dis Date: 2005-03-15 Impact factor: 2.830
Authors: Audrey H Calderwood; Joseph C Anderson; Christina M Robinson; Lynn F Butterly Journal: Am J Gastroenterol Date: 2018-11-02 Impact factor: 10.864
Authors: Terry C Davis; Connie L Arnold; Michael S Wolf; Charles L Bennett; Dachao Liu; Alfred Rademaker Journal: J Community Support Oncol Date: 2015-02
Authors: Joanna Buscemi; Yazmin San Miguel; Lisa Tussing-Humphreys; Elizabeth A Watts; Marian L Fitzgibbon; Karriem Watson; Robert A Winn; Kameron L Matthews; Yamile Molina Journal: Contemp Clin Trials Date: 2016-11-22 Impact factor: 2.226
Authors: Connie L Arnold; Alfred W Rademaker; James D Morris; Laurie Anne Ferguson; Gary Wiltz; Terry C Davis Journal: Cancer Date: 2019-07-29 Impact factor: 6.860
Authors: Stacy N Davis; Shannon M Christy; Enmanuel A Chavarria; Rania Abdulla; Steven K Sutton; Alyssa R Schmidt; Susan T Vadaparampil; Gwendolyn P Quinn; Vani N Simmons; Chukwudi B Ufondu; Chitra Ravindra; Ida Schultz; Richard G Roetzheim; David Shibata; Cathy D Meade; Clement K Gwede Journal: Cancer Date: 2016-12-01 Impact factor: 6.860
Authors: Terry C Davis; Alfred Rademaker; Charles L Bennett; Michael S Wolf; Edson Carias; Cristalyn Reynolds; Dachao Liu; Connie L Arnold Journal: J Gen Intern Med Date: 2013-12-24 Impact factor: 5.128
Authors: Giridhar Mohan; Sajal K Chattopadhyay; Donatus U Ekwueme; Susan A Sabatino; Devon L Okasako-Schmucker; Yinan Peng; Shawna L Mercer; Anilkrishna B Thota Journal: Am J Prev Med Date: 2019-08-30 Impact factor: 5.043